Claudio Tamarit, Maria Pellicer-Roca, María Alias-Ferrí, Carlos Roncero, Javier Didia-Attas, Francina Fonseca, Julián Andrés Mateus, Joan I MestrePintó, Marta Torrens
求助PDF
{"title":"PRISM-5更新:基于DSM-5标准的双重诊断评估的西班牙语版访谈的改编和验证。","authors":"Claudio Tamarit, Maria Pellicer-Roca, María Alias-Ferrí, Carlos Roncero, Javier Didia-Attas, Francina Fonseca, Julián Andrés Mateus, Joan I MestrePintó, Marta Torrens","doi":"10.1016/j.sjpmh.2025.09.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diagnosing individuals with co-occurring substance use and other mental disorders (SUDs and MDs) is challenging due to overlapping symptoms and masking effects. Semi-structured interviews, like the Psychiatric Research Interview for Substance and Mental Disorders (PRISM), are essential for diagnostic accuracy. This study aims to update and validate the Spanish PRISM-IV to DSM-5 criteria, providing evidence of reliability based on its ability to assess Dual Disorders (DDs).</p><p><strong>Material and methods: </strong>The PRISM-5 was translated and culturally adapted to Spanish to ensure equivalence with the original English version. The interview was computerized using BLAISE© software and pilot-tested. A cross-sectional study with patients recruited from specialized treatment centers in Spain and Argentina compared PRISM-5 diagnoses to those established through the Longitudinal, Expert, All Data (LEAD) method, providing evidence of diagnostic agreement through Cohen's kappa coefficient.</p><p><strong>Results: </strong>197 patients were recruited (69% male, mean age = 35.6). PRISM-5 showed substantial evidence of diagnostic agreement for most SUDs (k = 0.62-0.77), including alcohol, cannabis, cocaine, heroin, sedative, and amphetamine use disorders, with excellent agreement for past heroin use disorder (k = 0.83). For MDs, substantial agreement was found for major depression, ADHD and psychotic, panic, and personality disorders (k = 0.63-0.73), while moderate agreement was observed for substance-induced and persistent depression (k = 0.59-0.60).</p><p><strong>Conclusions: </strong>PRISM-5 provided strong evidence of diagnostic reliability in its Spanish version, with substantial agreement across most diagnoses. Compared to the PRISM-IV, it showed similar evidence of reliability, with some notable improvements in areas such as alcohol and cannabis use disorders. These findings underscore the instrument's robustness and value for diagnosing DDs.</p>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PRISM-5 Update: Adaptation and validation of the Spanish Version Interview for Dual Diagnosis Assessment Based on DSM-5 Criteria.\",\"authors\":\"Claudio Tamarit, Maria Pellicer-Roca, María Alias-Ferrí, Carlos Roncero, Javier Didia-Attas, Francina Fonseca, Julián Andrés Mateus, Joan I MestrePintó, Marta Torrens\",\"doi\":\"10.1016/j.sjpmh.2025.09.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Diagnosing individuals with co-occurring substance use and other mental disorders (SUDs and MDs) is challenging due to overlapping symptoms and masking effects. Semi-structured interviews, like the Psychiatric Research Interview for Substance and Mental Disorders (PRISM), are essential for diagnostic accuracy. This study aims to update and validate the Spanish PRISM-IV to DSM-5 criteria, providing evidence of reliability based on its ability to assess Dual Disorders (DDs).</p><p><strong>Material and methods: </strong>The PRISM-5 was translated and culturally adapted to Spanish to ensure equivalence with the original English version. The interview was computerized using BLAISE© software and pilot-tested. A cross-sectional study with patients recruited from specialized treatment centers in Spain and Argentina compared PRISM-5 diagnoses to those established through the Longitudinal, Expert, All Data (LEAD) method, providing evidence of diagnostic agreement through Cohen's kappa coefficient.</p><p><strong>Results: </strong>197 patients were recruited (69% male, mean age = 35.6). PRISM-5 showed substantial evidence of diagnostic agreement for most SUDs (k = 0.62-0.77), including alcohol, cannabis, cocaine, heroin, sedative, and amphetamine use disorders, with excellent agreement for past heroin use disorder (k = 0.83). For MDs, substantial agreement was found for major depression, ADHD and psychotic, panic, and personality disorders (k = 0.63-0.73), while moderate agreement was observed for substance-induced and persistent depression (k = 0.59-0.60).</p><p><strong>Conclusions: </strong>PRISM-5 provided strong evidence of diagnostic reliability in its Spanish version, with substantial agreement across most diagnoses. Compared to the PRISM-IV, it showed similar evidence of reliability, with some notable improvements in areas such as alcohol and cannabis use disorders. These findings underscore the instrument's robustness and value for diagnosing DDs.</p>\",\"PeriodicalId\":101179,\"journal\":{\"name\":\"Spanish Journal of Psychiatry and Mental Health\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spanish Journal of Psychiatry and Mental Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.sjpmh.2025.09.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spanish Journal of Psychiatry and Mental Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.sjpmh.2025.09.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
PRISM-5 Update: Adaptation and validation of the Spanish Version Interview for Dual Diagnosis Assessment Based on DSM-5 Criteria.
Introduction: Diagnosing individuals with co-occurring substance use and other mental disorders (SUDs and MDs) is challenging due to overlapping symptoms and masking effects. Semi-structured interviews, like the Psychiatric Research Interview for Substance and Mental Disorders (PRISM), are essential for diagnostic accuracy. This study aims to update and validate the Spanish PRISM-IV to DSM-5 criteria, providing evidence of reliability based on its ability to assess Dual Disorders (DDs).
Material and methods: The PRISM-5 was translated and culturally adapted to Spanish to ensure equivalence with the original English version. The interview was computerized using BLAISE© software and pilot-tested. A cross-sectional study with patients recruited from specialized treatment centers in Spain and Argentina compared PRISM-5 diagnoses to those established through the Longitudinal, Expert, All Data (LEAD) method, providing evidence of diagnostic agreement through Cohen's kappa coefficient.
Results: 197 patients were recruited (69% male, mean age = 35.6). PRISM-5 showed substantial evidence of diagnostic agreement for most SUDs (k = 0.62-0.77), including alcohol, cannabis, cocaine, heroin, sedative, and amphetamine use disorders, with excellent agreement for past heroin use disorder (k = 0.83). For MDs, substantial agreement was found for major depression, ADHD and psychotic, panic, and personality disorders (k = 0.63-0.73), while moderate agreement was observed for substance-induced and persistent depression (k = 0.59-0.60).
Conclusions: PRISM-5 provided strong evidence of diagnostic reliability in its Spanish version, with substantial agreement across most diagnoses. Compared to the PRISM-IV, it showed similar evidence of reliability, with some notable improvements in areas such as alcohol and cannabis use disorders. These findings underscore the instrument's robustness and value for diagnosing DDs.